MC
Manavi Chatterjee
Yale University
Research areas: Medicine · Complementary and alternative medicine · Neuroscience and Neuropharmacology Research · Schizophrenia research and treatment · Protein Tyrosine Phosphatases
Employment
-
Yale University Associate Research Scientist2017 - Present
-
Yale University Postdoc Associate2012 - 2017
Education
Education history is unavailable.
Projects & Funding
-
Inhibitors of STEP in the treatment of Fragile X Syndrome Brain and Behavior Research Foundation2017 - 2019
-
STEP Inhibition ameliorates epileptic symptoms in Fragile-X-syndrome Yale Epilepsy Center2016 - 2018
-
Inhibitors of STEP as a novel treatment of fragile X syndrome FRAXA Research Foundation2014 - 2016
Publications (18)
- STEP inhibition reverses behavioral, electrophysiologic, and synaptic abnormalities in Fmr1 KO mice Save
- Aspm knockout ferret reveals an evolutionary mechanism governing cerebral cortical size letter Save
- Antipsychotic activity of standardized Bacopa extract against ketamine-induced experimental psychosis in mice: Evidence for the involvement of dopaminergic, serotonergic, and cholinergic systems Save
- Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer's disease Save
- Substrate-Based fragment identification for the development of selective, nonpeptidic inhibitors of striatal-enriched protein tyrosine phosphatase Save
- Anxiolytic effects of Plumeria rubra var. acutifolia (Poiret) L. flower extracts in the elevated plus-maze model of anxiety in mice Save
- Evaluation of the Antipsychotic Potential of Panax quinquefolium in Ketamine Induced Experimental Psychosis Model in Mice Save
- Antidepressant and anxiolytic effects of amentoflavone isolated from Cnestis ferruginea in mice Save
- Comparative Evaluation of Forced Swim Test and Tail Suspension Test as Models of Negative Symptom of Schizophrenia in Rodents Save
- Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice Save
- Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Save
- Sir-2.1 modulates ‘calorie-restriction-mediated’ prevention of neurodegeneration in Caenorhabditis elegans: Implications for Parkinson’s disease Save
- Discovery and synthesis of novel 3-phenylcoumarin derivatives as antidepressant agents Save
- Effect of 'chronic' versus 'acute' ketamine administration and its 'withdrawal' effect on behavioural alterations in mice: Implications for experimental psychosis Save
- Evaluation of ethanol leaf extract of Ocimum sanctum in experimental models of anxiety and depression Save
- Oxidative stress: A novel treatment target in psychiatric disorder Save
- Antidepressant and anxiolytic potentials of dichloromethane fraction from Hedranthera barteri Save
- Comparative evaluation of Bacopa monniera and Panax quniquefolium in experimental anxiety and depressive models in mice Save